ArticlePharmacoEconomics2025

Innovative Payment Models for Sickle-Cell Disease Gene Therapies in Medicaid: Leveraging Real-World Data and Insights from CMMI's Gene Therapy Access Model.

Antal Zemplenyi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.